Longboard Pharmaceuticals, Inc. (LBPH) Financial Statements (2023 and earlier)

Company Profile

Business Address 4275 EXECUTIVE SQUARE
LA JOLLA, CA 92037
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

Current Assets
Cash, cash equivalents, and short-term investments, including:67,600106,700
Cash and cash equivalents10,77566,346
Short-term investments56,81440,379
Other undisclosed cash, cash equivalents, and short-term investments11(25)
Other undisclosed current assets2,2381,684
Total current assets:69,838108,384
Noncurrent Assets
Operating lease, right-of-use asset736521
Property, plant and equipment914
Long-term investments and receivables3333
Long-term investments3333
Total noncurrent assets:778568
TOTAL ASSETS:70,616108,952
Current Liabilities
Accounts payable and accrued liabilities1,8002,860
Employee-related liabilities1,480
Accounts payable1,3101,028
Accrued liabilities490352
Other undisclosed current liabilities6,9642,584
Total current liabilities:8,7645,444
Noncurrent Liabilities
Long-term debt and lease obligation: 185
Liabilities, other than long-term debt382 
Operating lease, liability382185
Total noncurrent liabilities:382370
Total liabilities:9,1465,814
Equity, attributable to parent61,470103,323
Common stock11
Additional paid in capital148,303145,683
Accumulated other comprehensive loss(692)(164)
Accumulated deficit(86,142)(42,197)
Total equity:61,470103,323
Other undisclosed liabilities and equity (185)

Income Statement (P&L) ($ in thousands)

Operating expenses(44,798)(27,839)
Operating loss:(44,798)(27,839)
Loss from continuing operations:(44,798)(27,839)
Loss before gain (loss) on sale of properties:(27,839)
Other undisclosed net income85342
Net loss available to common stockholders, diluted:(43,945)(27,797)

Comprehensive Income ($ in thousands)

Net loss:(43,945)(27,797)
Comprehensive loss:(43,945)(27,797)
Other undisclosed comprehensive loss, net of tax, attributable to parent(528)(164)
Comprehensive loss, net of tax, attributable to parent:(44,473)(27,961)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios


Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: